# Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines

> **NCT06246552** · PHASE2 · COMPLETED · sponsor: **Jetema USA Inc.** · enrollment: 480 (actual)

## Conditions studied

- Glabellar Lines

## Interventions

- **BIOLOGICAL:** JTM201
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06246552
- **Lead sponsor:** Jetema USA Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-26
- **Primary completion:** 2025-06-05
- **Final completion:** 2025-06-05
- **Target enrollment:** 480 (ACTUAL)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06246552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06246552, "Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06246552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*